Viral and Non-viral Vectors in Gene Therapy

Technology Development and Clinical Trials

  • Lundstrom, Kenneth Ph.D.
  • Boulikas, Teni
Technology in Cancer Research and Treatment 2(5):p 471-485, October 2003. | DOI: 10.1177/153303460300200513

Gene therapy as part of modern molecular medicine holds great promise for the treatment of both acute and chronic diseases and has the potential to bring a revolutionary era to cancer treatment. Gene therapy has been named the medicine of the future. For the past 10 years various viral and non-viral vectors have been engineered for improved gene and drug delivery. Although various diseases have been targeted, cancer therapy has been addressed to a large extent because of the straight forward approach. Delivery of toxic or immunostimulatory genes by viral and non-viral vectors has been investigated and encouraging results have been obtained in animal models. A large number of clinical trials have been conducted with some highly promising outcome. We propose that combinations of viruses with lipo-somes or polymers will solve the problem of systemic viral delivery and tumor targeting, bringing a revolution in molecular medicine and in applications of gene therapy in humans.

Copyright ©2003Sage Publications